Home » Topics » BioWorld Science

BioWorld Science
RSS

Medshine Discovery patents MAPK 14 inhibitors

April 20, 2018

Vertex Pharmaceuticals identifies new PAR-2 antagonists

April 20, 2018

Plexxikon divulges novel IDO1 and/or TDO inhibitors

April 20, 2018

Relay Therapeutics and collaborator patent PTP-2C inhibitors

April 20, 2018

EMA committee hands down negative opinion for masitinib in ALS

April 20, 2018

Novel genetically altered broadly neutralizing antibodies protect monkeys from SHIV

April 20, 2018

FDA advisory committee recommends approval of Epidiolex for LGS and Dravet syndrome

April 20, 2018

Johnson & Johnson reviews progress of first quarter 2018

April 20, 2018

ADC Therapeutics presents potent antitumoral compounds in xenograft models

April 20, 2018

FDA accepts Veloxis' sNDA for Envarsus XR

April 20, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...